Cargando…

Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials

Detalles Bibliográficos
Autores principales: Zhang, Chenyue, Wang, Haiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016961/
https://www.ncbi.nlm.nih.gov/pubmed/33795635
http://dx.doi.org/10.1038/s41392-021-00557-9
_version_ 1783673964869976064
author Zhang, Chenyue
Wang, Haiyong
author_facet Zhang, Chenyue
Wang, Haiyong
author_sort Zhang, Chenyue
collection PubMed
description
format Online
Article
Text
id pubmed-8016961
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80169612021-04-16 Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials Zhang, Chenyue Wang, Haiyong Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2021-04-01 /pmc/articles/PMC8016961/ /pubmed/33795635 http://dx.doi.org/10.1038/s41392-021-00557-9 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Highlight
Zhang, Chenyue
Wang, Haiyong
Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
title Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
title_full Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
title_fullStr Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
title_full_unstemmed Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
title_short Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
title_sort therapeutic utility of lung-map: ushering into an era of genomic and biomarker-driven clinical trials
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016961/
https://www.ncbi.nlm.nih.gov/pubmed/33795635
http://dx.doi.org/10.1038/s41392-021-00557-9
work_keys_str_mv AT zhangchenyue therapeuticutilityoflungmapusheringintoaneraofgenomicandbiomarkerdrivenclinicaltrials
AT wanghaiyong therapeuticutilityoflungmapusheringintoaneraofgenomicandbiomarkerdrivenclinicaltrials